Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1959 Nov;52(11):929–932. doi: 10.1177/003591575905201109

Some Aspects of New Corticosteroids

R I S Bayliss
PMCID: PMC1870820  PMID: 13797831

Full text

PDF
929

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAYLISS R. I. Cortisone and its analogues in endocrinology. Postgrad Med J. 1958 Jun;34(392):305–309. doi: 10.1136/pgmj.34.392.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOLAND E. W. 16a-Methyl corticosteroids; a new series of anti-inflammatory compounds; clinical appraisal of their antirheumatic potencies. Calif Med. 1958 Jun;88(6):417–422. [PMC free article] [PubMed] [Google Scholar]
  3. BUNIM J. J., BLACK R. L., LUTWAK L., PETERSON R. E., WHEDON G. D. Studies on dexamethasone, a new synthetic steroid, in rheurheumatoid arthritis: a preliminary report; adrenal cortical, metabolic and early clinical effects. Arthritis Rheum. 1958 Aug;1(4):313–331. doi: 10.1002/art.1780010404. [DOI] [PubMed] [Google Scholar]
  4. ELLIS J. T. Necrosis and regeneration of skeletal muscles in cortisone-treated rabbits. Am J Pathol. 1956 Sep-Oct;32(5):993–1013. [PMC free article] [PubMed] [Google Scholar]
  5. FAJANS S. S., CONN J. W. An approach to the prediction of diabetes mellitus by modification of the glucose tolerance test with cortisone. Diabetes. 1954 Jul-Aug;3(4):296-302; discussion, 302-4. doi: 10.2337/diab.3.4.296. [DOI] [PubMed] [Google Scholar]
  6. HART F. D., GOLDING J. R., BURLEY D. Triamcinolone. Lancet. 1958 Sep 6;2(7045):495–498. doi: 10.1016/s0140-6736(58)91284-4. [DOI] [PubMed] [Google Scholar]
  7. KENDALL P. H., HART M. F. Side-effects following triamcinolone. Br Med J. 1959 Mar 14;1(5123):682–685. doi: 10.1136/bmj.1.5123.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MACLEAN K., SCHURR P. H. Reversible amyotrophy complicating treatment with fludrocortisone. Lancet. 1959 Apr 4;1(7075):701–703. doi: 10.1016/s0140-6736(59)91886-0. [DOI] [PubMed] [Google Scholar]
  9. NABARRO J. D., WALKER G. Treatment of adrenal cortical insufficiency. Br Med J. 1957 Jul 6;2(5035):17–19. doi: 10.1136/bmj.2.5035.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. ROBECCHI A., DANEO V., DI VITTORIO S., EINAUDI G., MARRAZZI G. Su un nuovo cortisonico di sintesi, il desametasone (16-alfa-metil-9-alfa-fluoro-prednisolone), nella terapia dell'artrite reumatoide. Minerva Med. 1958 Nov 10;49(90):4163–4171. [PubMed] [Google Scholar]
  11. ROBINSON C. E., ROBINSON H. S. Triamcinolone in rheumatoid arthritis. Can Med Assoc J. 1959 Feb 15;80(4):245–247. [PMC free article] [PubMed] [Google Scholar]
  12. SLATER J. D., HEFFRON P. F., VERNET A., NABARRO J. D. Clinical and metabolic effects of dexamethasone. Lancet. 1959 Jan 24;1(7065):173–177. doi: 10.1016/s0140-6736(59)90370-8. [DOI] [PubMed] [Google Scholar]
  13. THOMPSON M. Triamcinolone in the treatment of rheumatoid arthritis. Br Med J. 1959 May 16;1(5132):1259–1262. doi: 10.1136/bmj.1.5132.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. VILLA L., BALLABIO C. B., SALA G. Effetti clinici e metabolici del 16-alfa metil-9 alfa-fluoroprednisolone o desametasone. Reumatismo. 1958 May-Jun;10(3):127–133. [PubMed] [Google Scholar]
  15. WELLS R. Triamcinolone arthritis? Lancet. 1958 Sep 6;2(7045):498–499. doi: 10.1016/s0140-6736(58)91285-6. [DOI] [PubMed] [Google Scholar]
  16. WILLIAMS R. S. Triamcinolone myopathy. Lancet. 1959 Apr 4;1(7075):698–701. doi: 10.1016/s0140-6736(59)91885-9. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES